With this study, we presented the essential role of cyth3 in vivo in IR-downstream signaling in liver and fat that leads to the prevention of age- and diet-induced obesity and therefore suggest cyth3 as a potentially interesting novel therapeutic target for metabolic diseases. This evidence concerns the gene CYTH3 and metabolic disease.